African American Drug Company Founder Announces Possible Coronavirus Treatment
|
Posted By: Will Moss on April 16, 2020 Ennaid Therapeutics is seeking FDA approval for drug that could help the afflicted. A Georgia-based pharmaceutical company is advancing the development of an antiviral drug that may potentially fight coronavirus cases, and which would be more easily administered to those afflicted by the disease. Darnisha Harrison, founder and CEO of Ennaid Therapeutics, one of the first African American women to start a major drug company, announced her company filed a patent when scientists working there created a therapeutic called ENU200 that could treat as much as 80 percent of asymptomatic, mild to moderate COVID-19 infections. Darnisha Grant Harrison is the President & CEO of Ennaid Therapeutics, a development-stage biopharmaceutical company. As the company’s Head, she is responsible for guiding the company to its intention of being first-to-market with the world’s first therapeutic cure for two of the most notorious mosquito-borne diseases in the world, Zika virus and dengue virus. There are a total of eleven drugs in the company’s pipeline. Once a Microbiologist and Chemist, Darnisha is now a nationally recognized pharmaceutical entrepreneur by Newsweek Magazine and has greater than twenty-four years’ experience in the Life Sciences. Prior to founding Ennaid Therapeutics, she spent three years as a scientist, most notably at Amgen and the University of Georgia, and sixteen years in Business Development/Licensing as a Director in various companies within the pharmaceutical research & development industry. She is an accomplished negotiator and deal-maker in identifying, negotiating and closing drug development deals and strategic collaborations. Darnisha is accomplished in technology acquisition and licensing, strategic business development, business planning and brisk, successful execution of such plans. A member of the American Association for the Advancement of Science, the New York Academy of Sciences, The World Chamber of Commerce and Women In BIO, Darnisha received a B.S. in Microbiology and Minor in Chemistry from LSU. Visit Ennaid Therapeutics website here: https://ennaidthera.com To subscribe to our website and receive more good news like this as soon as it comes out, goto https://hbcuconnect.com/signup If you enjoyed this article, Join HBCU CONNECT today for similar content and opportunities via email! |
 |
Will Moss
Founder & CEO, HBCU CONNECT, LLC Hampton University class of 1995 Member Since June 1999 |
Comments
More From This Author
Latest News
Popular News
 |
North Carolina HBCU Unity DayShaw University - Elizabeth City State University - Johnson C. Smith University - Fayetteville State University - Livingstone College - North Carolina A&T State University - North Carolina Central Uni ...more
Reginald Culpepper • 104,290 Views • August 8th, 2016 |
